M W Audeh - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M W Audeh

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of the American Geriatrics Society|May 1, 1982

Small cell lung carcinoma in the elderlyG H Clamon, M W Audeh, S Pinnick

American Journal of Clinical Oncology|August 1, 1990

A phase II trial of carbetimer for the treatment of colorectal cancer. A trial of the Northern California Oncology GroupM W Audeh, C D Jacobs, T E Davis, et al.

Cancer|May 1, 1988

Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphomaJ G Strickler, M W Audeh, C M Copenhaver, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safetyU A Matulonis, R T Penson, S M Domchek, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of the American Geriatrics Society|May 1, 1982

Small cell lung carcinoma in the elderlyG H Clamon, M W Audeh, S Pinnick

American Journal of Clinical Oncology|August 1, 1990

A phase II trial of carbetimer for the treatment of colorectal cancer. A trial of the Northern California Oncology GroupM W Audeh, C D Jacobs, T E Davis, et al.

Cancer|May 1, 1988

Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphomaJ G Strickler, M W Audeh, C M Copenhaver, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safetyU A Matulonis, R T Penson, S M Domchek, et al.

Pageof 1